Back to Newsroom

Regado Biosciences Announces Closing of Public Offering of Common Stock

BASKING RIDGE, N.J., April 16, 2014 /PRNewswire/ — Regado Biosciences, Inc. (Nasdaq: RGDO), today announced the closing of its previously announced underwritten public offering. The gross proceeds to Regado from its sale of 10,000,000 shares of common stock at a price to the public of $6.00 per share were approximately $60.0 million, prior to deducting underwriting discounts and commissions and other offering expenses payable by Regado.

Click here to read more